Sanofi warns on '13 profit as Q2 earns slump (Update)

August 1, 2013

Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.

The Paris-based drugmaker reported Thursday that net profit shrank 62 percent to 444 million euros ($592 million) in the April to June quarter, as the loss of patent on once-popular blood-thinner Plavix compounded further massive financial charges related to the company's past mergers and acquisitions.

Sanofi warned that its preferred measure of profits—what it calls business EPS at constant exchange rates—will fall by 7 to 10 percent this year. Profit slumped 12.8 percent by that measure last year and until now the company had foreseen at most a 5 percent decline this year.

Profits by that measure collapsed a full 25 percent in the first half, but in a statement Thursday Sanofi said it "continues to expect to return to growth in the second half of 2013," making up for some of the losses.

Besides losses stemming from generic competitors, Sanofi pointed to a steep drop in its own generics business during the second quarter. It blamed "significantly and inappropriately" excessive inventory levels in its Brazilian operations, leading to a 122 million euro drop in sales there.

Sanofi's "growth platforms", the core businesses such as diabetes treatments and vaccines that it counts on for nearly three-quarters of total sales, slipped 0.6 percent to 5.718 billion euros in the second quarter.

Sanofi shares dropped sharply on the weak earnings and by mid-morning were down 6.3 percent at 75.17 euro a share.

In China, where last month officials launched a probe looking into the cost of drugs made by 60 foreign and domestic suppliers, Sanofi said it is among the companies visited.

There was no indication of wrongdoing, but the probe could be a prelude to a cut in government-set caps on prices.

Sanofi said it is "not aware of the purpose of this visit" and said it would cooperate with authorities.

Explore further: Profit at drugmaker Sanofi up 35 pct for 1st half

Related Stories

Profit at drugmaker Sanofi up 35 pct for 1st half

July 26, 2012

(AP) — Drugmaker Sanofi saw its net profit rise 35 percent in the first half of the year as it pushes into areas with long-term growth potential to off-set the expiration of profitable patents.

Bristol-Myers, Sanofi revamp Plavix sales alliance (Update)

October 3, 2012

(AP)—Bristol-Myers Squibb Co. and France's Sanofi SA said Wednesday that they are restructuring their longtime partnership selling popular heart medications, now that their sales are plunging due to widespread competition ...

Merck Q4 net profit more than doubles

March 7, 2013

Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.

Sanofi earnings slashed in first quarter

May 2, 2013

(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.

SAP profit up 10 percent in second quarter

July 18, 2013

(AP)—Business software maker SAP AG said net profit grew 10 percent in the second quarter to 724 million euros ($948 million) despite the economic slowdown in Asia.

Bayer Q2 profits jump on new drugs, lower charges (Update)

July 31, 2013

German drug and chemicals company Bayer AG says net profit rose 75 percent in the second quarter thanks to lower one-time charges and strong sales of new products including anti-clotting drug Xarelto and cancer drug Stivarga.

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.